Citation: Current Treatment Options in Gastroenterology. 2018 Jan 19.Journal: Current treatment options in gastroenterology.Published: 2018ISSN: 1092-8472.Full author list: Parsa N; Khashab MA.UI/PMID: 29350340.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Harbor HospitalDepartment(s): PediatricsActivity type: Journal Article.Medline article type(s): Journal Article | ReviewDigital Object Identifier: https://dx.doi.org/10.1007/s11938-018-0168-0 (Click here)Abbreviated citation: Curr Treat Options Gastroenterol. 2018 Jan 19.Abstract: OPINION STATEMENT: PURPOSE OF THE REVIEW: Peroral endoscopic myotomy (POEM) is a novel minimally invasive technique that has emerged as the preferred option for the treatment of achalasia and spastic esophageal disorders (SED) at many centers around the world. In this article, we review and summarize the recent literature on POEM in patients with achalasia and SED. The current article is largely focused on the new developments and findings, extended applications, and long-term outcomes of POEM in patients with achalasia and SED.Abstract: RECENT FINDINGS: POEM is a safe and effective therapy for patients with achalasia and SED. POEM is comparable to Heller myotomy (HM) in terms of safety, efficacy, and complications, including gastroesophageal reflux disease (GERD). Outcomes of POEM are excellent even in patients who had prior failed therapies for achalasia, including failed HM and prior POEM. Recent data also suggest the efficacy and safety of POEM in both pediatric and geriatric patients. GERD after POEM is common, and the majority of patients are asymptomatic. The management, goals of therapy, and long-term outcomes of GERD after POEM are unclear. Objective testing for all patients is recommended. POEM is a validated treatment for all patients with achalasia and SED. Candidates should be carefully selected and appropriately counseled on expected outcomes and the need for long-term surveillance.